Implementation of a treat-to-target remission strategy for rheumatoid arthritis in Australian public and private rheumatology clinics

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Rheumatoid arthritis (RA) is a common and incurable inflammatory joint disease affecting 2% of Australians. RA is associated with significant pain, disability, loss of work capacity and reduced life expectancy. Research has shown that 'treating to a target' for the goal of remission significantly improves outcomes for people living with RA. This TRIP fellowship will assess the barriers to clinicians and people living with RA managing the disease in a targeted way and develop a package to assist.

Funded Activity Details

Start Date: 01-01-2016

End Date: 01-01-2017

Funding Scheme: Translating Research into Practice Fellowships

Funding Amount: $178,157.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Rheumatology and Arthritis

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

implementation | musculoskeletal | rheumatoid arthritis | rheumatology | translational research